FC

Finepoint Capital Portfolio holdings

AUM $504M
This Quarter Return
-12.73%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$289M
AUM Growth
+$289M
Cap. Flow
+$2.08M
Cap. Flow %
0.72%
Top 10 Hldgs %
62.75%
Holding
82
New
19
Increased
–
Reduced
–
Closed
22

Top Buys

1
FOLD icon
Amicus Therapeutics
FOLD
$21.6M
2
ARGX icon
argenx
ARGX
$20M
3
CYTK icon
Cytokinetics
CYTK
$16.5M
4
SRPT icon
Sarepta Therapeutics
SRPT
$15.8M
5
SAGE
Sage Therapeutics
SAGE
$15.4M

Top Sells

1
REVH
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$21.2M
2
HAAC
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$18.1M
3
CCV
Churchill Capital Corp V
CCV
$17.8M
4
CCVI
Churchill Capital Corp VI
CCVI
$16.8M
5
CPAR
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$16.4M

Sector Composition

1 Healthcare 86.56%
2 Materials 11.54%
3 Energy 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ASTL icon
1
Algoma Steel
ASTL
$511M
$33.4M 11.54% 3,716,732 – –
FOLD icon
2
Amicus Therapeutics
FOLD
$2.34B
$21.6M 7.47% +2,010,900 New +$21.6M
ARGX icon
3
argenx
ARGX
$43.6B
$20M 6.92% +52,800 New +$20M
CYTK icon
4
Cytokinetics
CYTK
$4.23B
$16.5M 5.7% +419,433 New +$16.5M
SRPT icon
5
Sarepta Therapeutics
SRPT
$1.78B
$15.8M 5.47% +211,000 New +$15.8M
SAGE
6
DELISTED
Sage Therapeutics
SAGE
$15.4M 5.31% +475,600 New +$15.4M
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
$15.1M 5.24% +474,000 New +$15.1M
ASND icon
8
Ascendis Pharma
ASND
$11.8B
$14.8M 5.13% +159,500 New +$14.8M
GLPG icon
9
Galapagos
GLPG
$2.07B
$14.5M 5.01% +259,400 New +$14.5M
APLS icon
10
Apellis Pharmaceuticals
APLS
$3.48B
$14.4M 4.98% +318,400 New +$14.4M
TVTX icon
11
Travere Therapeutics
TVTX
$1.56B
$14.2M 4.9% +584,300 New +$14.2M
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$14.1M 4.88% +210,200 New +$14.1M
RCUS icon
13
Arcus Biosciences
RCUS
$1.13B
$13.6M 4.69% +535,000 New +$13.6M
PRTA icon
14
Prothena Corp
PRTA
$441M
$12.4M 4.29% +457,500 New +$12.4M
RARE icon
15
Ultragenyx Pharmaceutical
RARE
$2.89B
$12.1M 4.19% +203,200 New +$12.1M
IOVA icon
16
Iovance Biotherapeutics
IOVA
$807M
$10.6M 3.67% +960,200 New +$10.6M
ACAD icon
17
Acadia Pharmaceuticals
ACAD
$4.38B
$9.96M 3.45% +707,200 New +$9.96M
ISEE
18
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$9.5M 3.29% +987,600 New +$9.5M
PTGX icon
19
Protagonist Therapeutics
PTGX
$3.67B
$5.82M 2.01% +735,126 New +$5.82M
GBTG.WS
20
DELISTED
Global Business Travel Group, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
GBTG.WS
$959K 0.33% +913,000 New +$959K
CRHC.WS
21
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$389K 0.13% 904,000 – –
IPOF.WS
22
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$322K 0.11% 671,000 – –
STRY.WS
23
DELISTED
Starry Group Holdings, Inc. Warrants, each whole warrant exercisable to purchase 1.2415 shares of Class A common stock at an exercise price of $11.50 per 1.2415 shares of Class A common stock
STRY.WS
$276K 0.1% 669,000 – –
KAHC.WS
24
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$212K 0.07% 588,547 – –
BTWNW
25
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$206K 0.07% 895,000 – –
1
2 3 4